Literature DB >> 16386234

Paralemmin interacts with D3 dopamine receptors: implications for membrane localization and cAMP signaling.

Maria Basile1, Ridwan Lin, Nadine Kabbani, Kelly Karpa, Manfred Kilimann, Ian Simpson, Mark Kester.   

Abstract

Paralemmin is a novel lipid-anchored protein, which is highly expressed in neuronal plasma membranes. In this study, we demonstrate that paralemmin specifically interacts with the third intracellular loop of the D3 dopamine receptor. Utilizing co-immunoprecipitation and glutathione-S-transferase (GST) pulldown strategies, we demonstrate that paralemmin interacts exclusively with D3, but not D2 or D4 dopamine receptors or beta-adrenergic receptors. Immunocytochemistry demonstrated co-localization of paralemmin and D3 receptor in vivo in hippocampus and cerebellum and in vitro in glial and neuronal cultures. Deletion mutational analysis indicates that amino acids 154-230 of paralemmin strongly interacted with amino acids 211-227 and 281-330 of the third intracellular loop of D3 receptor. The consequences of these interactions were investigated by co-expression in HEK293 cells. Cell surface biotinylation experiments demonstrate that paralemmin decreased D3 receptor concentration at the plasma membrane. Consistent with this observation, paralemmin expression decreased dopamine-stimulated adenylate cyclase activity. However, paralemmin also decreased basal, isoproterenol and forskolin-stimulated adenylate cyclase activity, suggesting a more general cellular function for paralemmin. Taken together, paralemmin has been implicated as a potent modulator of cellular cAMP signaling within the brain.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16386234     DOI: 10.1016/j.abb.2005.10.027

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  12 in total

1.  Regulation of dopamine D3 receptors by protein-protein interactions.

Authors:  Ming-Lei Guo; Xian-Yu Liu; Li-Min Mao; John Q Wang
Journal:  Neurosci Bull       Date:  2010-04       Impact factor: 5.203

Review 2.  The potential role of dopamine D₃ receptor neurotransmission in cognition.

Authors:  Shinichiro Nakajima; Philip Gerretsen; Hiroyoshi Takeuchi; Fernando Caravaggio; Tiffany Chow; Bernard Le Foll; Benoit Mulsant; Bruce Pollock; Ariel Graff-Guerrero
Journal:  Eur Neuropsychopharmacol       Date:  2013-06-20       Impact factor: 4.600

Review 3.  Beyond small-molecule SAR: using the dopamine D3 receptor crystal structure to guide drug design.

Authors:  Thomas M Keck; Caitlin Burzynski; Lei Shi; Amy Hauck Newman
Journal:  Adv Pharmacol       Date:  2014

4.  Cellular and subcellular localization of paralemmin-1, a protein involved in cell shape control, in the rat brain, adrenal gland and kidney.

Authors:  Christian Kutzleb; Elisabeth Petrasch-Parwez; Manfred W Kilimann
Journal:  Histochem Cell Biol       Date:  2006-07-18       Impact factor: 4.304

5.  Paralemmin-1, a modulator of filopodia induction is required for spine maturation.

Authors:  Pamela Arstikaitis; Catherine Gauthier-Campbell; Rosario Carolina Gutierrez Herrera; Kun Huang; Joshua N Levinson; Timothy H Murphy; Manfred W Kilimann; Carlo Sala; Michael A Colicos; Alaa El-Husseini
Journal:  Mol Biol Cell       Date:  2008-02-20       Impact factor: 4.138

6.  Dopamine D4 receptor, but not the ADHD-associated D4.7 variant, forms functional heteromers with the dopamine D2S receptor in the brain.

Authors:  S González; C Rangel-Barajas; M Peper; R Lorenzo; E Moreno; F Ciruela; J Borycz; J Ortiz; C Lluís; R Franco; P J McCormick; N D Volkow; M Rubinstein; B Floran; S Ferré
Journal:  Mol Psychiatry       Date:  2011-08-16       Impact factor: 15.992

7.  Isolation and characterization of the TIGA genes, whose transcripts are induced by growth arrest.

Authors:  Norikazu Yabuta; Hiroaki Onda; Masafumi Watanabe; Naohisa Yoshioka; Ippei Nagamori; Tomoyuki Funatsu; Shingo Toji; Katsuyuki Tamai; Hiroshi Nojima
Journal:  Nucleic Acids Res       Date:  2006-09-14       Impact factor: 16.971

8.  Evolution of the vertebrate paralemmin gene family: ancient origin of gene duplicates suggests distinct functions.

Authors:  Greta Hultqvist; Daniel Ocampo Daza; Dan Larhammar; Manfred W Kilimann
Journal:  PLoS One       Date:  2012-07-25       Impact factor: 3.240

9.  Paralemmin-1 is over-expressed in estrogen-receptor positive breast cancers.

Authors:  Casey M Turk; Katerina D Fagan-Solis; Kristin E Williams; Joseph M Gozgit; Sallie Smith-Schneider; Sharon A Marconi; Christopher N Otis; Giovanna M Crisi; Douglas L Anderton; Manfred W Kilimann; Kathleen F Arcaro
Journal:  Cancer Cell Int       Date:  2012-05-10       Impact factor: 5.722

10.  Detection of patient subgroups with differential expression in omics data: a comprehensive comparison of univariate measures.

Authors:  Maike Ahrens; Michael Turewicz; Swaantje Casjens; Caroline May; Beate Pesch; Christian Stephan; Dirk Woitalla; Ralf Gold; Thomas Brüning; Helmut E Meyer; Jörg Rahnenführer; Martin Eisenacher
Journal:  PLoS One       Date:  2013-11-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.